Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2015 Aug 19;8(9):1034–1041. doi: 10.1016/j.jcmg.2015.06.007

Table 1.

Baseline characteristics of the study population.

LVH
Eccentric Concentric
Variable No LVH
N=1728
Indeterminate
N=404
Dilated
N=30
Thick
N = 289
Both
N=7
Age (yrs) 43 [36, 52] 43 [36, 51] 42.5 [35, 46] 49 [42, 56]* 53 [46, 58]
Men (%) 51.8 13.6* 43.3 40.8* 85.7
Black (%) 40.8 54.9* 73.3* 78.9* 71.4
BMI 27.5 [24.1, 31] 35.1 [31, 40.3]* 27.0 [24.3, 34.6] 34.4 [29.8, 39.7]* 32.7 [28.7, 44.6]
Hypertension (%) 23.4 37.1 36.7 73.8* 85.7*
SBP 122 [112, 131] 125 [115, 138]* 131 [122, 141] 141 [128, 155]* 145 [128, 159]
DBP 76 [71, 82] 79 [73, 85]* 76 [74, 83] 85 [78, 92]* 86 [76, 89]
Diabetes (%) 7.3 10.9 6.7 23.9* 57.1*
CVD (%) 2.7 2.7 3.3 10.4* 14.3
eGFR (ml/min per 1.73 m2) 95.8 [84.0, 109.3] 102.9 [90.8, 116.3]* 111.4 [94.9, 135.7]* 95.4 [81.6, 110.2] 97.3 [81.1, 111.4]
LV EF 73 [68, 77] 75 [71, 80]* 72 [59, 76] 72 [67, 78] 62 [45, 76]
LV Mass/Height2.7 36.0 [32.1, 39.5] 44 [41.2, 48.8]* 52.9 [48.1, 59.9]* 51.9 [46.7, 57.4]* 65.8 [63.7, 69]*
LV Mass/BSA 76.9 [66.9, 88.9] 78.0 [73.4, 85.6]* 108.7 [92.5, 126.4]* 99.8 [85.7, 115.9]* 143.5 [124.7, 145.7]*
LV EDV/BSA 50.7 [44.7, 57.3] 53.0 [47.5, 57.8]* 81.1 [70.6, 91.7]* 47.8 [41.0, 55.9]* 79.6 [74.4, 87.5]*
Concentricity0.67 7.0 [6.2, 8] 7.2 [6.7, 7.7] 7.4 [6.4, 7.8] 9.5 [9, 10.6]* 9.7 [9.2, 9.8]*
LV Wall Thickness 11.0 [10, 12.2] 11.3 [10.8, 12.1]* 12.1 [10.7, 12.8] 14.0 [13.1, 15.1]* 15.4 [14.5, 16.1]*

Values are reported as median [25%, 75% percentile] or proportion (%) where indicated.

*

p < 0.001 versus no LVH group.

p < 0.01 versus no LVH group.

LVH = left ventricular hypertrophy. BMI = body mass index. SBP = systolic blood pressure. DBP = diastolic blood pressure. CVD = cardiovascular disease. eGFR = estimated glomerular filtration rate. LV = left ventricle. EF = ejection fraction. EDV = end diastolic volume. BSA = body surface area.